Anlon Healthcare Board of Directors
Get the latest insights into the leadership at Anlon Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Punitkumar R Rasadia | Chairman & Managing Director |
| Mr. Meet Atulkumar Vachhani | Whole Time Director |
| Ms. Mamata Punitkumar Rasadia | Non Executive Director |
| Mr. Shailesh Kantilal Thakkar | Ind. Non-Executive Director |
| Mr. Anandbhai Natwerlal Katkoria | Ind. Non-Executive Director |
| Mr. Kannepalli Krishna Murty | Ind. Non-Executive Director |
Anlon Healthcare Share price
AHCL
91.01
0.72 (-0.78%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High
91.70
Today's Low
91.00
52 Week Low
90.78
52 Week High
92.50
The current prices are delayed, login to your account for live prices
LoginAnlon Healthcare FAQs
The board at Anlon Healthcare consists of experienced professionals, including Mr. Punitkumar R Rasadia , Mr. Meet Atulkumar Vachhani , and others, overseeing the company’s strategic and corporate governance.
Directors at Anlon Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Punitkumar R Rasadia is the current chairman at Anlon Healthcare.
Executive directors at Anlon Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Anlon Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Anlon Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.